Q2 2023 Earnings Presentation

Driving long-term shareholder value с Growth & Innovation Global leader in digital health for sleep and respiratory care • Long-term growth opportunities. • 9,300+ patents and designs • ~7-8% of revenue invested in R&D . 0000 Market Dynamics Underpenetrated markets in sleep and COPD Healthcare costs continue to increase Focus on improving patient outcomes Value-based technology solutions Financial Results Historical revenue and profit growth • Recurring revenue Operating excellence program Strong track record of disciplined capital deployment ResMed is the global leader in connected & digital health 12 2023 ResMed | Q2 2023 Earnings Presentation - Jan. 26, 2023 ResMed

View entire presentation